{"@context":{"owl":"http://www.w3.org/2002/07/owl#","bibo":"http://purl.org/ontology/bibo/","foaf":"http://xmlns.com/foaf/0.1/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/"},"@id":"https://ci.nii.ac.jp/ncid/AA12668558.json","@graph":[{"@id":"https://ci.nii.ac.jp/ncid/AA12668558#entity","@type":"bibo:Journal","foaf:isPrimaryTopicOf":{"@id":"https://ci.nii.ac.jp/ncid/AA12668558.json"},"dc:title":[{"@value":"Canadian adverse drug reaction newsletter"}],"dcterms:alternative":["Canadian ADR newsletter","Canadian adverse drug reaction newsletter"],"dc:publisher":[{"@value":"Drugs Directorate, Health Canada"}],"dcterms:extent":"v.","cinii:size":"28 cm","dc:language":"eng","dc:date":"19--","cinii:ncid":"AA12668558","cinii:ownerCount":"1","foaf:maker":[{"@type":"foaf:Person","foaf:name":[{"@value":"Canada. Drugs Directorate"}]}],"bibo:owner":[{"@id":"https://ci.nii.ac.jp/library/FA026802","@type":"foaf:Organization","foaf:name":"日本医薬情報センター 附属図書館"}],"bibo:lccn":["97702025"],"rdfs:seeAlso":[{"@id":"https://lccn.loc.gov/97702025"}],"prism:publicationDate":["-2002"],"cinii:note":["Description based on: Vol. 6, no. 1 (Jan. 1996)","Title from caption","Running title: Canadian ADR newsletter, <Vol. 12, no. 1 (Jan. 2002)>","Issued by: Therapeutic Products Directrate, <Vol. 12, no. 1 (Jan. 2002)>"],"cinii:volumeYear":"-v. 12, no. 1 (Jan. 2002)","cinii:familyid":"42230700","dc:relation":[{"@id":"https://ci.nii.ac.jp/ncid/AA12668569#entity","dc:title":"Canadian adverse reaction newsletter"}]}]}